CKPT insider transactions

Large owner Fortress Biotech, Inc. sold $129,000 worth of shares (100,000 units at $1.29) and returned $25,101,221 worth of shares to the company (6,122,249 units at $4.10), closing all direct ownership in the company (SEC Form 4)

Director Weiss Michael S was granted 62,195 shares, increasing direct ownership by 36% to 187,007 units (SEC Form 4)

Director Salzman Barry M was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)

Director Rosenwald Lindsay A Md was granted 62,195 shares, closing all direct ownership in the company (SEC Form 4)

CEO, President and Director Oliviero James F Iii closing all direct ownership in the company (SEC Form 4)

Director Herskowitz Neil was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)

Chief Financial Officer Gray William Garrett closing all direct ownership in the company (SEC Form 4)

Director Bechon Christian was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)

Director Amit Sharma was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)

CEO, President and Director Oliviero James F Iii sold $60,964 worth of shares (15,090 units at $4.04), decreasing direct ownership by 0.40% to 3,759,929 units (SEC Form 4)

Chief Financial Officer Gray William Garrett sold $49,904 worth of shares (12,322 units at $4.05), decreasing direct ownership by 0.84% to 1,446,322 units (SEC Form 4)

Large owner Fortress Biotech, Inc. was granted 18,500 shares, increasing direct ownership by 0.30% to 6,222,249 units (SEC Form 4)

CEO, President and Director Oliviero James F Iii sold $64,027 worth of shares (19,564 units at $3.27), decreasing direct ownership by 0.52% to 3,775,019 units (SEC Form 4)

Chief Financial Officer Gray William Garrett sold $271,984 worth of shares (74,110 units at $3.67), decreasing direct ownership by 5% to 1,458,644 units (SEC Form 4)

Chief Financial Officer Gray William Garrett was granted 500,000 shares, increasing direct ownership by 48% to 1,532,754 units (SEC Form 4)

CEO, President and Director Oliviero James F Iii was granted 1,500,000 shares, increasing direct ownership by 65% to 3,794,583 units (SEC Form 4)

Large owner Fortress Biotech, Inc. was granted 2,468,215 shares, increasing direct ownership by 66% to 6,203,749 units (SEC Form 4)

CEO, President and Director Oliviero James F Iii gifted 900,000 shares and sold $3,074,764 worth of shares (822,397 units at $3.74), decreasing direct ownership by 43% to 2,294,583 units (SEC Form 4)

Chief Financial Officer Gray William Garrett sold $1,076,412 worth of shares (268,432 units at $4.01), decreasing direct ownership by 21% to 1,032,754 units (SEC Form 4)

Director Weiss Michael S was granted 12,638 shares (SEC Form 4)

Director Salzman Barry M was granted 17,638 shares, increasing direct ownership by 15% to 134,812 units (SEC Form 4)

Director Rosenwald Lindsay A Md was granted 12,638 shares, increasing direct ownership by 10% to 144,812 units (SEC Form 4)

CEO, President and Director Oliviero James F Iii was granted 2,077,700 shares, increasing direct ownership by 107% to 4,016,980 units (SEC Form 4)

Chief Financial Officer Gray William Garrett was granted 629,000 shares, increasing direct ownership by 94% to 1,301,186 units (SEC Form 4)

Director Bechon Christian was granted 14,994 shares, increasing direct ownership by 13% to 129,523 units (SEC Form 4)

Director Herskowitz Neil was granted 17,638 shares, increasing direct ownership by 15% to 134,812 units (SEC Form 4)

Large owner Fortress Biotech, Inc. was granted 146,341 shares, increasing direct ownership by 4% to 3,735,534 units (SEC Form 4)

CEO, President and Director Oliviero James F Iii sold $50,450 worth of shares (24,610 units at $2.05) and gifted 37,890 shares, decreasing direct ownership by 3% to 1,939,280 units (SEC Form 4)

Chief Financial Officer Gray William Garrett sold $26,858 worth of shares (13,038 units at $2.06), decreasing direct ownership by 2% to 672,186 units (SEC Form 4)

Gray William Garrett was granted 540,000 shares, increasing direct ownership by 372% to 685,224 units (SEC Form 4)

Oliviero James F Iii was granted 1,660,000 shares, increasing direct ownership by 486% to 2,001,780 units (SEC Form 4)

New insider Fortress Biotech, Inc. claimed ownership of 3,589,193 shares (SEC Form 3)

Weiss Michael S was granted 82,051 shares (SEC Form 4)

Amit Sharma was granted 32,051 shares, increasing direct ownership by 64% to 82,051 units (SEC Form 4)

Salzman Barry M was granted 82,051 shares, increasing direct ownership by 234% to 117,174 units (SEC Form 4)

Rosenwald Lindsay A Md was granted 82,051 shares, increasing direct ownership by 164% to 132,174 units (SEC Form 4)

Herskowitz Neil was granted 82,051 shares, increasing direct ownership by 234% to 117,174 units (SEC Form 4)

Bechon Christian was granted 82,051 shares, increasing direct ownership by 253% to 114,529 units (SEC Form 4)

Fortress Biotech, Inc. was granted 193,905 shares, increasing direct ownership by 10% to 2,096,278 units (SEC Form 4)

New insider Amit Sharma claimed ownership of 50,000 shares (SEC Form 3)

Oliviero James F Iii sold $12,142 worth of shares (5,894 units at $2.06) and gifted 9,056 shares, decreasing direct ownership by 4% to 341,780 units (SEC Form 4)

Gray William Garrett sold $4,212 worth of shares (2,035 units at $2.07), decreasing direct ownership by 1% to 145,224 units (SEC Form 4)

Gray William Garrett sold $8,024 worth of shares (4,115 units at $1.95), decreasing direct ownership by 3% to 147,259 units (SEC Form 4)

Oliviero James F Iii sold $23,919 worth of shares (11,900 units at $2.01) and gifted 12,950 shares, decreasing direct ownership by 7% to 356,730 units (SEC Form 4)

Oliviero James F Iii gifted 42,000 shares, decreasing direct ownership by 10% to 381,580 units (SEC Form 5)

Fortress Biotech, Inc. was granted 158,134 shares, increasing direct ownership by 9% to 1,902,373 units (SEC Form 4)

Fortress Biotech, Inc. was granted 80,906 shares, increasing direct ownership by 5% to 1,744,239 units (SEC Form 4)

SEC Form 4 filed by Fortress Biotech, Inc.

SEC Form 4 filed by Weiss Michael S

SEC Form 4 filed by Rosenwald Lindsay A Md

SEC Form 4 filed by Salzman Barry M

SEC Form 4 filed by Herskowitz Neil

SEC Form 4 filed by Bechon Christian

SEC Form 4 filed by Boilen Scott

SEC Form 4 filed by Oliviero James F Iii

SEC Form 4 filed by Gray William Garrett

SEC Form 4 filed by Fortress Biotech, Inc.

SEC Form 4: Gray William Garrett sold $15,108 worth of shares (3,154 units at $4.79), decreasing direct ownership by 6% to 49,379 units (for withholding tax)

SEC Form 4: Oliviero James F Iii sold $48,945 worth of shares (10,261 units at $4.77), decreasing direct ownership by 5% to 182,121 units (withholding tax)

SEC Form 4: Gray William Garrett sold $12,540 worth of shares (1,858 units at $6.75), decreasing direct ownership by 3% to 52,533 units (for withholding tax)